Meissner HC - Search Results

1

Viral Bronchiolitis in Children.

Meissner HC. Meissner HC. N Engl J Med. 2016 Jan 7;374(1):62-72. doi: 10.1056/NEJMra1413456. N Engl J Med. 2016. PMID: 26735994 Review. No abstract available.

2

Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group.

Groothuis JR, Simoes EA, Levin MJ, Hall CB, Long CE, Rodriguez WJ, Arrobio J, Meissner HC, Fulton DR, Welliver RC, et al. Groothuis JR, et al. Among authors: meissner hc. N Engl J Med. 1993 Nov 18;329(21):1524-30. doi: 10.1056/NEJM199311183292102. N Engl J Med. 1993. PMID: 8413475 Clinical Trial.

3

More on Viral Bronchiolitis in Children.

Meissner HC. Meissner HC. N Engl J Med. 2016 Sep 22;375(12):1200. doi: 10.1056/NEJMc1607283. N Engl J Med. 2016. PMID: 27653586 No abstract available.

4

Viral Bronchiolitis in Children.

Meissner HC. Meissner HC. N Engl J Med. 2016 May 5;374(18):1793-4. doi: 10.1056/NEJMc1601509. N Engl J Med. 2016. PMID: 27144864 No abstract available.

5

Economic impact of viral respiratory disease in children.

Meissner HC. Meissner HC. J Pediatr. 1994 May;124(5 Pt 2):S17-21. doi: 10.1016/s0022-3476(94)70186-5. J Pediatr. 1994. PMID: 8169753 Free PMC article. Review.

6

Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis.

Ralston SL, Lieberthal AS, Meissner HC, Alverson BK, Baley JE, Gadomski AM, Johnson DW, Light MJ, Maraqa NF, Mendonca EA, Phelan KJ, Zorc JJ, Stanko-Lopp D, Brown MA, Nathanson I, Rosenblum E, Sayles S 3rd, Hernandez-Cancio S; American Academy of Pediatrics. Ralston SL, et al. Among authors: meissner hc. Pediatrics. 2014 Nov;134(5):e1474-502. doi: 10.1542/peds.2014-2742. Pediatrics. 2014. PMID: 25349312

7

Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group.

Guerina NG, Hsu HW, Meissner HC, Maguire JH, Lynfield R, Stechenberg B, Abroms I, Pasternack MS, Hoff R, Eaton RB, et al. Guerina NG, et al. Among authors: meissner hc. N Engl J Med. 1994 Jun 30;330(26):1858-63. doi: 10.1056/NEJM199406303302604. N Engl J Med. 1994. PMID: 7818637

8

Respiratory syncytial virus immunoprophylaxis: impact on epidemiology.

Dougherty NN, Meissner HC. Dougherty NN, et al. Among authors: meissner hc. Paediatr Drugs. 2000 Mar-Apr;2(2):127-32. doi: 10.2165/00148581-200002020-00005. Paediatr Drugs. 2000. PMID: 10937464 Clinical Trial.

9

Safety and pharmacokinetics of an intramuscular monoclonal antibody (SB 209763) against respiratory syncytial virus (RSV) in infants and young children at risk for severe RSV disease.

Meissner HC, Groothuis JR, Rodriguez WJ, Welliver RC, Hogg G, Gray PH, Loh R, Simoes EA, Sly P, Miller AK, Nichols AI, Jorkasky DK, Everitt DE, Thompson KA. Meissner HC, et al. Antimicrob Agents Chemother. 1999 May;43(5):1183-8. doi: 10.1128/AAC.43.5.1183. Antimicrob Agents Chemother. 1999. PMID: 10223933 Free PMC article. Clinical Trial.

10

Immunoprophylaxis with palivizumab, a humanized respiratory syncytial virus monoclonal antibody, for prevention of respiratory syncytial virus infection in high risk infants: a consensus opinion.

Meissner HC, Welliver RC, Chartrand SA, Law BJ, Weisman LE, Dorkin HL, Rodriguez WJ. Meissner HC, et al. Pediatr Infect Dis J. 1999 Mar;18(3):223-31. doi: 10.1097/00006454-199903000-00004. Pediatr Infect Dis J. 1999. PMID: 10093942 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results